Evidence map›Paper›PMID 35381108›Full record

ArticleAngewandte Chemie (International ed. in English)2022

Divergent Asymmetric Synthesis of Panowamycins, TM-135, and Veramycin F Using C-H Insertion with Donor/Donor Carbenes.

Benjamin D Bergstrom, Amy T Merrill, James C Fettinger, Dean J Tantillo, Jared T Shaw

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Ligand-controlled divergent asymmetric C(spNature communications · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Benjamin D BergstromDepartment of Chemistry, University of California, Davis, One Shields Ave., Davis, CA 95161, USA.ORCID 0000-0003-2179-1334
Amy T MerrillDepartment of Chemistry, University of California, Davis, One Shields Ave., Davis, CA 95161, USA.ORCID 0000-0003-4801-1721
James C FettingerDepartment of Chemistry, University of California, Davis, One Shields Ave., Davis, CA 95161, USA.ORCID 0000-0002-6428-4909
Dean J TantilloDepartment of Chemistry, University of California, Davis, One Shields Ave., Davis, CA 95161, USA.ORCID 0000-0002-2992-8844
Jared T ShawDepartment of Chemistry, University of California, Davis, One Shields Ave., Davis, CA 95161, USA.ORCID 0000-0001-5190-493X

Funding

Synthesis of Diverse Natural Products and Complex Heterocycles with Donor/Donor CarbenoidsR01GM124234 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI SHAW, JARED THOMAS · 2018 to 2021
$1.3M
NIGMS NIH HHS R01 GM124234NIGMS NIH HHS R01/GM124234
6 · The paper itself

Abstract

Panowamycins are a group of isochroman-based natural products first isolated from Streptomyces sp. K07-0010 in 2012 by Satoshi Ōmura and co-workers that exhibit modest anti-trypanosomal activity. Herein we demonstrate the first syntheses of these natural products and their epimers. Stereoselective dirhodium-catalyzed C-H insertion reactions with a donor/donor carbene construct the substituted isochroman core in the key bond-forming step. The syntheses are completed without the use of protecting groups and feature a late-stage Wacker oxidation. Incongruent NMR spectra between natural and synthetic samples revealed the structural misassignment of panowamycin A and veramycin F. Computational NMR studies suggested panowamycin A to be an alternate diastereomer, which was confirmed by synthesizing this isomer. Concurrent with this work, in 2021 Mahmud and co-workers came to the same conclusion with an updated NMR analysis of panowamycin A. In a divergent, asymmetric sequence, we report the synthesis of panowamycin A, panowamycin B, TM-135, and veramycin F.

Indexed as

Biological ProductsMethaneCatalysisHumansOxidation-ReductionBiological ProductscarbeneMethaneAsymmetric CatalysisC−H InsertionDonor/Donor CarbeneTotal Synthesis

Identifiers

PMID35381108
PMCPMC9189068

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.